...
axdx-img

Accelerate Diagnostics Inc, Common Stock

AXDX

NAQ

$1.22

+$0.02

(1.67%)

1D
Industry: Life Sciences Tools & Services Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$30.05M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
15.39K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.60
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.73 L
$4.41 H
$1.22

About Accelerate Diagnostics Inc, Common Stock

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona. more

Industry: Life Sciences Tools & ServicesSector: Health Care

Returns

Time FrameAXDXSectorS&P500
1-Week Return-9.09%-3.39%-3.47%
1-Month Return-33.33%-3.25%-0.29%
3-Month Return-18.37%-11.61%4.5%
6-Month Return3.45%-5.89%6.91%
1-Year Return-73.45%2.65%23.79%
3-Year Return-97.51%0.56%28.43%
5-Year Return-99.29%34.63%83.64%
10-Year Return-99.34%94.78%185.94%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue9.30M11.16M11.78M12.75M12.06M[{"date":"2019-12-31","value":72.91,"profit":true},{"date":"2020-12-31","value":87.55,"profit":true},{"date":"2021-12-31","value":92.39,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":94.57,"profit":true}]
Cost of Revenue4.90M6.71M12.16M9.45M9.51M[{"date":"2019-12-31","value":40.26,"profit":true},{"date":"2020-12-31","value":55.13,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":77.69,"profit":true},{"date":"2023-12-31","value":78.18,"profit":true}]
Gross Profit4.40M4.46M(381.00K)3.30M2.55M[{"date":"2019-12-31","value":98.68,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-8.54,"profit":false},{"date":"2022-12-31","value":74.07,"profit":true},{"date":"2023-12-31","value":57.19,"profit":true}]
Gross Margin47.33%39.94%(3.23%)25.90%21.15%[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":84.39,"profit":true},{"date":"2021-12-31","value":-6.83,"profit":false},{"date":"2022-12-31","value":54.73,"profit":true},{"date":"2023-12-31","value":44.68,"profit":true}]
Operating Expenses77.23M68.16M71.18M66.11M56.58M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":88.25,"profit":true},{"date":"2021-12-31","value":92.16,"profit":true},{"date":"2022-12-31","value":85.6,"profit":true},{"date":"2023-12-31","value":73.26,"profit":true}]
Operating Income(72.83M)(63.70M)(71.56M)(62.80M)(54.03M)[{"date":"2019-12-31","value":-7283100000,"profit":false},{"date":"2020-12-31","value":-6370000000,"profit":false},{"date":"2021-12-31","value":-7156000000,"profit":false},{"date":"2022-12-31","value":-6280500000,"profit":false},{"date":"2023-12-31","value":-5402800000,"profit":false}]
Total Non-Operating Income/Expense(23.03M)(29.20M)(21.55M)(2.98M)(12.48M)[{"date":"2019-12-31","value":-2303200000,"profit":false},{"date":"2020-12-31","value":-2919800000,"profit":false},{"date":"2021-12-31","value":-2155400000,"profit":false},{"date":"2022-12-31","value":-298500000,"profit":false},{"date":"2023-12-31","value":-1247700000,"profit":false}]
Pre-Tax Income(84.42M)(78.20M)(77.66M)(62.57M)(60.77M)[{"date":"2019-12-31","value":-8441600000,"profit":false},{"date":"2020-12-31","value":-7820300000,"profit":false},{"date":"2021-12-31","value":-7765700000,"profit":false},{"date":"2022-12-31","value":-6257000000,"profit":false},{"date":"2023-12-31","value":-6076800000,"profit":false}]
Income Taxes(111.00K)5.00K45.00K(77.00K)850.00K[{"date":"2019-12-31","value":-13.06,"profit":false},{"date":"2020-12-31","value":0.59,"profit":true},{"date":"2021-12-31","value":5.29,"profit":true},{"date":"2022-12-31","value":-9.06,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes(84.31M)(78.21M)(77.70M)(62.49M)(61.62M)[{"date":"2019-12-31","value":-8430500000,"profit":false},{"date":"2020-12-31","value":-7820800000,"profit":false},{"date":"2021-12-31","value":-7770200000,"profit":false},{"date":"2022-12-31","value":-6249300000,"profit":false},{"date":"2023-12-31","value":-6161800000,"profit":false}]
Income From Continuous Operations(84.31M)(78.21M)(77.70M)(62.49M)(63.23M)[{"date":"2019-12-31","value":-8430500000,"profit":false},{"date":"2020-12-31","value":-7820800000,"profit":false},{"date":"2021-12-31","value":-7770200000,"profit":false},{"date":"2022-12-31","value":-6249300000,"profit":false},{"date":"2023-12-31","value":-6322900000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(84.31M)(78.21M)(77.70M)(62.49M)(61.62M)[{"date":"2019-12-31","value":-8430500000,"profit":false},{"date":"2020-12-31","value":-7820800000,"profit":false},{"date":"2021-12-31","value":-7770200000,"profit":false},{"date":"2022-12-31","value":-6249300000,"profit":false},{"date":"2023-12-31","value":-6161800000,"profit":false}]
EPS (Diluted)(1.54)(1.40)(1.27)(0.76)(2.15)[{"date":"2019-12-31","value":-154,"profit":false},{"date":"2020-12-31","value":-140,"profit":false},{"date":"2021-12-31","value":-127,"profit":false},{"date":"2022-12-31","value":-76,"profit":false},{"date":"2023-12-31","value":-215,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

AXDX
Cash Ratio 1.15
Current Ratio 1.50
Quick Ratio 1.34

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

AXDX
ROA (LTM) -75.85%
ROE (LTM) 0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

AXDX
Debt Ratio Lower is generally better. Negative is bad. 2.50
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -1.50

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

AXDX
Trailing PE NM
Forward PE NM
P/S (TTM) 2.46
P/B 0.00
Price/FCF NM
EV/R 5.61
EV/Ebitda NM
PEG NM

FAQs

What is Accelerate Diagnostics Inc share price today?

Accelerate Diagnostics Inc (AXDX) share price today is $1.22

Can Indians buy Accelerate Diagnostics Inc shares?

Yes, Indians can buy shares of Accelerate Diagnostics Inc (AXDX) on Vested. To buy Accelerate Diagnostics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in AXDX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Accelerate Diagnostics Inc be purchased?

Yes, you can purchase fractional shares of Accelerate Diagnostics Inc (AXDX) via the Vested app. You can start investing in Accelerate Diagnostics Inc (AXDX) with a minimum investment of $1.

How to invest in Accelerate Diagnostics Inc shares from India?

You can invest in shares of Accelerate Diagnostics Inc (AXDX) via Vested in three simple steps:

  • Click on Sign Up or Invest in AXDX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Accelerate Diagnostics Inc shares
What is Accelerate Diagnostics Inc 52-week high and low stock price?

The 52-week high price of Accelerate Diagnostics Inc (AXDX) is $4.41. The 52-week low price of Accelerate Diagnostics Inc (AXDX) is $0.73.

What is Accelerate Diagnostics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Accelerate Diagnostics Inc (AXDX) is

What is Accelerate Diagnostics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Accelerate Diagnostics Inc (AXDX) is 0.00

What is Accelerate Diagnostics Inc dividend yield?

The dividend yield of Accelerate Diagnostics Inc (AXDX) is 0.00%

What is the Market Cap of Accelerate Diagnostics Inc?

The market capitalization of Accelerate Diagnostics Inc (AXDX) is $30.05M

What is Accelerate Diagnostics Inc’s stock symbol?

The stock symbol (or ticker) of Accelerate Diagnostics Inc is AXDX

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top